News about ISCIII

Hospital Clínic-IDIBAPS, pioneer in CAR T-cell therapies for cancer with over 500 patients treated

Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regulat1

Clínic Barcelona

Research March 28 2025

Colonoscopy and faecal occult blood tests are equivalent in detecting colorectal cancer

Researchers at IDIBAPS-Hospital Clínic and Hospital Universitario de Canarias have coordinated a study involving 57,000 people that compares the effe1

Clínic Barcelona

Institutional July 8 2024

IDIBAPS, newly reaccredited as an institute for health research by the Carlos III Health Institute

IDIBAPS successfully and positively achieved its first reaccreditation in 2014, and its second in 2019.

Clínic Barcelona

Research December 17 2021

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1

News about ISCIII

Hospital Clínic-IDIBAPS, pioneer in CAR T-cell therapies for cancer with over 500 patients treated

Colonoscopy and faecal occult blood tests are equivalent in detecting colorectal cancer

IDIBAPS, newly reaccredited as an institute for health research by the Carlos III Health Institute

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

Subscribe to the Newsletter of Clínic